Specific immunotherapy in asthma: a comprehensive review

References

• WHO Position Paper. Allergen immunotherapy: therapeutical vaccines for allergic diseases. Allergy 1998;54:1–33
   Google Scholar
• Cox L. Allergen immunotherapy and asthma: efficacy, safety, and other considerations. Allergy Asthma Proc 2008;29:580–589
   Google Scholar
• Cruz AA, Popov T, Pawankar R, Annesi-Maesano I, Fokkens W, Kemp J, Ohta K, Price D, et al. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy 2007;62:1–41
   PubMed Web of Science ®Google Scholar
• Bousquet PJ, Brozek J, Bachert C, Bieber T, Bonini S, Burney P, Calderon M, Canonica GW, et al. The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper. Allergy 2009;64:1737–1745
   PubMed Web of Science ®Google Scholar
• Canonica GW, Baena-Cagnani CE, Bousquet J, Bousquet PJ, Lockey RF, Malling HJ, Passalacqua G, Potter P, et al. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 2007;62:317–324
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Canonica GW. Specific immunotherapy in asthma. Efficacy and safety. Clin Exp Allergy 2011;41:1247–1255
   PubMedGoogle Scholar
• Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev 2010;8:CD001186
   PubMed Web of Science ®Google Scholar
• Erekosima N, Suarez-Cuervo C, Ramanathan M, Kim JM, Chelladurai Y, Segal JB, Lin SY. Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review. Laryngoscope 2013. (Epub ahead of print)
   Google Scholar
• Calamita Z, Saconato H, Bronhara Pelà A, Atallah AN. Efficacy of Sublingual immunotherapy in asthma. Systematic review of randomized clinical trials. Allergy 2006;61:1162–1172
   PubMed Web of Science ®Google Scholar
• Penagos M, Passalacqua G, Compalati E, Tarantini F, Canonica GW. Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 2008;133:599–609
   PubMed Web of Science ®Google Scholar
• Canonica GW editor. World Allergy Organization position paper on sublingual immunotherapy. Allergy 2009;64:1–59
   Google Scholar
• Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, Nelson M, Weber R, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol 2011;127:S1–S55
   PubMed Web of Science ®Google Scholar
• Paranos S, Petrovic S. Early effects of rush immunotherapy with Dermatophagoides pteronyssinus in asthmatics. J Investig Allergol Clin Immunol 1997;7:588–595
   Google Scholar
• Grembiale RD, Camporota L, Naty S, Tranfa CM, Djukanovic R, Marsico SA. Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000;162:2048–2052
   PubMed Web of Science ®Google Scholar
• Varney VA, Tabbah K, Mavroleon G, Frew AJ. Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial. Clin Exp Allergy 2003;33:1076–1082
   PubMed Web of Science ®Google Scholar
• Ferrer A, García-Sellés J. Significant improvement in symptoms, skin test, and specific bronchial reactivity after 6 months of treatment with a depigmented, polymerized extract of Dermatophagoides pteronyssinus and D. farinae. J Investig Allergol Clin Immunol 2003;13:244–251
   Google Scholar
• Wang H, Lin X, Hao C, Zhang C, Sun B, Zheng J, Chen P, Sheng J, et al. double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients. Allergy 2006;61:191–197
   PubMed Web of Science ®Google Scholar
• Tabar AI, Lizaso MT, García BE, Gómez B, Echechipía S, Aldunate MT, Madariaga B, Martínez A, et al. Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: clinical efficacy and safety. Pediatr Allergy Immunol 2008;19:67–75
   Google Scholar
• Pham-Thi N, Scheinmann P, Fadel R, Combebias A, Andre C. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures. Pediatr Allergy Immunol 2007;18:47–57
   PubMed Web of Science ®Google Scholar
• Hirsch T, Sahn M, Leupold W. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite in children. Pediatr Allergy Immunol 1997;8:21–27
   PubMed Web of Science ®Google Scholar
• Dahl R, Stender H, Rak S. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Allergy 2006;61:185–190
   PubMed Web of Science ®Google Scholar
• Stelmach I, Kaczmarek-Woźniak J, Majak P, Oszlowiek-Chlebna M, Jerzynska A. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen. Clin Exp Allergy 2009;39:401–408
   PubMed Web of Science ®Google Scholar
• Bufe A, Eberle P, Franke-Beckmann E, Funck J, Kimmig M, Klimek L. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009;123:167–173
   PubMed Web of Science ®Google Scholar
• Niu CK, Chen WY, Huang JL, Lue KH, Wang YJ. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan. Respir Med 2006;100:1374–1383
   PubMed Web of Science ®Google Scholar
• Compalati E, Passalacqua G, Bonini M, Canonica GW. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis. Allergy 2009;64:1570–1579
   PubMed Web of Science ®Google Scholar
• Di Bona D, Plaia A, Scafidi V, Di Lorenzo G. Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a systematic review and meta-analysis. J Allergy Clin Immunol 2010;126:558–566
   PubMed Web of Science ®Google Scholar
• Rak S, Heinrich C, Jacobsen L, Scheynius A, Venge P. A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma. J Allergy Clin Immunol 2001;108:921–928
   Google Scholar
• Shaikh WA. Immunotherapy vs inhaled budesonide in bronchial asthma: an open, parallel, comparative trial. Clin Exp Allergy 1997;27:1279–1284
   PubMedGoogle Scholar
• Pajno GB, Vita D, Parmiani S, Caminiti L, La Grutta S, Barberio G. Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate. Clin Exp Allergy 2003;33:1641–1647
   PubMed Web of Science ®Google Scholar
• Marogna M, Spadolini I, Massolo A, Berra D, Zanon P, Chiodini E, Passalacqua G, et al. Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen. Ann Allergy Asthma Immunol 2009;102:69–75
   PubMed Web of Science ®Google Scholar
• Cox L, Larenas Linneman D, Lockey RF, Passalacqua G. Speaking a common language in immunotherapy. WAO grading of systemic reactions. J Allergy Clin Immunol 2010;125:569–574
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Baena Cagnani C, Bousquet J, Canonica GW, Cox L, Durham S, Durham SR, Larenas-Linnemann D, et al. Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. J Allergy Clin Immunol 2013;132:93–98
   PubMed Web of Science ®Google Scholar
• Lockey RF, Benedicts LM, Turkeltaub PC, Platt-Mills TA. Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol 1987;76:660–677
   Google Scholar
• Reid MJ, Lockey RF, Turkeltaub PC, Platt-Mills TA. Survey of fatalities from skin testing and immunotherapy. J Allergy Clin Immunol 1993;92:6--15
   Google Scholar
• Bernstein DI, Wanner M, Borish L, Liss GM; Immunotherapy Committee American Academy Allergy Asthma Immunology. Twelve years of survey of fatal reactions to allergen injections and skin testing 1990–2001. J Allergy Clin Immunol 2004;113:1129–1136
   PubMed Web of Science ®Google Scholar
• Lin MS, Tanner E, Lynn J, Friday GA jr. Non fatal systemic allergic reactions induced by skin test and immunotherapy. Ann Allergy 1993;71:557–562
   PubMedGoogle Scholar
• Hetal S, Amin HS, Liss GM, Bernstein DI. Evaluation of near-fatal reactions to allergen immunotherapy injections. J Allergy Clin Immunol 2006;117:169–175
   Google Scholar
• Tinkelman DG, Cole 3rd WQ, Tunno J. Immunotherapy: a one-year prospective study to evaluate risk factors of systemic reactions. J Allergy Clin Immunol 1995;95:8–14
   PubMed Web of Science ®Google Scholar
• Cox L, Jacobsen L. Comparison of allergen immunotherapy practice patterns in the United States and Europe. Ann Allergy Asthma Immunol 2009;103:451–459
   PubMed Web of Science ®Google Scholar
• Baena Cagnani CE, Larenas D, Sisul C, Gomez M, Sanchez Borges M, Canonica GW, Gereda J, Passalacqua G. Allergy training and immunotherapy in Latin America: results of a regional overview. Ann Allergy Asthma Immunol 2013;111:415--419
   Google Scholar
• Epstein TG, Liss GM, Murphy-Berendts K, Bernstein DI. AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, Year 3: what practices modify the risk of systemic reactions? Ann Allergy Asthma Immunol 2013;110:274–278
   PubMed Web of Science ®Google Scholar
• Committee on the Safety of Medicines. Desensitizing vaccines. BMJ 1989;293:948
   Google Scholar
• Ragusa RF, Passalacqua G, Gambardella R, Campanari S, Barbieri MM, Scordamaglia A, Canonica GW. Nonfatal systemic reactions to subcutaneous immunotherapy: a 10 years experience. J Invest Allergol Clin Immunol 1997;7:151–154
   PubMed Web of Science ®Google Scholar
• Moreno C, Cuesta-Herranza J, Fernandez-Tavora L, Alvarez-Cuesta E. Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases. Clin Exp Allergy 2004;34:527–531
   PubMed Web of Science ®Google Scholar
• Schiappoli M, Ridolo E, Senna G, Alesina R, Antonicelli L, Asero R, Costantino MT, Longo R, et al. A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergy. Clin Exp Allergy 2009;39:1569–1574
   PubMed Web of Science ®Google Scholar
• Rank MA, Oslie CL, Krogman JL, Park MA, Li JT. Allergen immunotherapy safety: characterizing systemic reactions and identifying risk factors. Allergy Asthma Proc 2008;29:400–405
   PubMed Web of Science ®Google Scholar
• Cox LS, Linnemann DL, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006;117:1021–1035
   PubMed Web of Science ®Google Scholar
• Calderón MA, Simons FE, Malling HJ, Lockey RF, Moingeon P, Demoly P. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile. Allergy 2012;67:302–311
   PubMed Web of Science ®Google Scholar
• Kleine-Tebbe J, Ribel M, Herold DA. Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial. Allergy 2006;61:181–184
   PubMed Web of Science ®Google Scholar
• Shaaban R, Zureik M, Soussan D, Neukirch C, Heinrich J, Sunyer J, Wjst M, Cerveri I, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 2008;372:1049–1057
   PubMed Web of Science ®Google Scholar
• Johnstone DE, Dutton A. The value of hyposensitization therapy for bronchial asthma in children – a 14-year study. Pediatrics 1968;42:793–802
   PubMed Web of Science ®Google Scholar
• Möller C, Dreborg S, Ferdousi HA, Halken S, Høst A, Jacobsen L, Koivikko A, Koller DY, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002;109:251–256
   PubMed Web of Science ®Google Scholar
• Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Høst A, Koivikko A, Norberg LA, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007;62:943–948
   PubMed Web of Science ®Google Scholar
• Novembre E, Galli E, Landi F, Caffarelli C, Pifferi M, De marco E, Burastero SE, Calori, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004;114:851–857
   PubMed Web of Science ®Google Scholar
• Marogna M, Tomassetti D, Bernasconi A, Colombo F, Massolo A, Businco A, Canonica GW, Passalacqua G, et al. Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study. Ann Allergy Asthma Immunol 2008;101:206–211
   PubMed Web of Science ®Google Scholar
• Brozek JL, Baena Cagnani C, Canonica GW, Bonini S, et al. Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy 2008;63:38–46
   PubMed Web of Science ®Google Scholar
• Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, et al. Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010;126:466–470
   PubMed Web of Science ®Google Scholar
• NHLBI Guidelines for the Diagnosis and Treatment of Asthma. www.nhbli.nih.gov/guidelines/asthma
   Google Scholar
• Passalacqua G, Canonica GW. Specific immunotherapy: beyond clinical scores. Ann Allergy Asthma Immunol 2011;107:401–406
   PubMed Web of Science ®Google Scholar
• Peng W, Liu E. Factors influencing the response to specific immunotherapy for asthma in children aged 5--16 years. Pediatr Int 2013. (Epub ahead of print)
   Google Scholar
• Pajno G, Caminiti L, Vita D, Crisafulli G, Valenzise M, De Luca R, Passalacqua G. Direct comparison between continuous and co-seasonal regimen for sublingual immunotherapy in children with grass allergy. Pediatr Allergy immunol 2011;22:803–807
   PubMed Web of Science ®Google Scholar
• Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G. Long lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. J Allergy Clin Immunol 2010;126:969–975
   PubMed Web of Science ®Google Scholar